A global trial has identified a better antibiotic for deadly staph infections. Published in NEJM, the trial, now involving over 6,000 people across 150 hospitals, found that cefazolin and, in some cases, penicillin, worked at least as well as flucloxacillin, the current standard treatment, but saw fewer deaths within 90 days and fewer cases of acute kidney injury. This is huge: staph infections kill up to 1 in 4 patients within three months. UCL https://www.ucl.ac.uk/news/2026/jun/global-trial-shows-safer-antibiotic-option-staph-blood-infection #ShareGoodNewsToo